Skip to main content
BMJ Open Access logoLink to BMJ Open Access
. 2018 Apr 16;55(6):422–429. doi: 10.1136/jmedgenet-2016-104178corr1

Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

PMCID: PMC5992370  PMID: 29661968

Hughes DA, Nicholls K, Shankar SP, et al. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet 2017;54:288–96.

The correct trial protocol number for this study is: NCT01218659.


Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES